Farma Nachtegaal: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Farma Nachtegaal
Largest movements
- Cash +€99,727
up €99,727 (+352%), from €28,300 to €128,027
mainly Net result for the year (+€162,955) and Current portion of long-term debt (+€734)
- Profit (loss) carried forward +€162,955
up €162,955, from €0 to €162,955
- Debts after one year -€52,122
down €52,122 (-15.4%), from €338,222 to €286,100
- Financial income +€53,095
new in 2025: €53,095
- Gross operating margin +€9,356
up €9,356 (+6.9%), from €136,557 to €145,912
- Taxes -€6,605
down €6,605 (-17.7%), from €37,289 to €30,684
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €890,945 | €990,553 | +€99,607 | +11.2% |
| Fixed assets | 21/28 | €850,000 | €850,000 | = | 0.0% |
| Financial fixed assets | 28 | €850,000 | €850,000 | = | 0.0% |
| Current assets | 29/58 | €40,945 | €140,553 | +€99,607 | +243% |
| Amounts receivable within one year | 40/41 | €12,241 | €12,118 | -€123 | -1.0% |
| Trade receivables | 40 | €12,100 | €12,100 | = | 0.0% |
| Other amounts receivable | 41 | €141 | €18 | -€123 | -87.2% |
| Cash at bank and in hand | 54/58 | €28,300 | €128,027 | +€99,727 | +352% |
| Deferred charges and accrued income | 490/1 | €404 | €408 | +€3 | +0.8% |
| Total equity and liabilities | 10/49 | €890,945 | €990,553 | +€99,607 | +11.2% |
| Equity | 10/15 | €175,777 | €338,732 | +€162,955 | +92.7% |
| Contributions | 10/11 | €1,000 | €1,000 | = | 0.0% |
| Reserves | 13 | €174,777 | €174,777 | = | 0.0% |
| Distributable reserves | 133 | €174,777 | €174,777 | = | 0.0% |
| Profit (loss) carried forward | 14 | €0 | €162,955 | +€162,955 | |
| Amounts payable | 17/49 | €715,168 | €651,820 | -€63,347 | -8.9% |
| Amounts payable after more than one year | 17 | €338,222 | €286,100 | -€52,122 | -15.4% |
| Financial debts | 170/4 | €338,222 | €286,100 | -€52,122 | -15.4% |
| Amounts payable within one year | 42/48 | €376,946 | €365,721 | -€11,225 | -3.0% |
| Current portion of amounts payable after more than one year | 42 | €51,388 | €52,122 | +€734 | +1.4% |
| Trade debts | 44 | €818 | €570 | -€249 | -30.4% |
| Suppliers | 440/4 | €818 | €570 | -€249 | -30.4% |
| Taxes, remuneration and social security | 45 | €9,626 | €7,161 | -€2,465 | -25.6% |
| Taxes | 450/3 | €6,467 | €7,161 | +€694 | +10.7% |
| Remuneration and social security | 454/9 | €3,159 | €0 | -€3,159 | -100% |
| Other amounts payable | 47/48 | €315,113 | €305,868 | -€9,246 | -2.9% |
| Other operating charges | 640/8 | €85 | €66 | -€19 | -22.7% |
| Gross operating margin | 9900 | €136,557 | €145,912 | +€9,356 | +6.9% |
| Operating profit (loss) | 9901 | €136,472 | €145,847 | +€9,375 | +6.9% |
| Financial income | 75/76B | - | €53,095 | +€53,095 | |
| Recurring financial income | 75 | - | €53,095 | +€53,095 | |
| Financial charges | 65/66B | €6,026 | €5,303 | -€723 | -12.0% |
| Recurring financial charges | 65 | €6,026 | €5,303 | -€723 | -12.0% |
| Profit (loss) for the period before taxes | 9903 | €130,446 | €193,639 | +€63,194 | +48.4% |
| Income taxes | 67/77 | €37,289 | €30,684 | -€6,605 | -17.7% |
| Profit (loss) for the period | 9904 | €93,157 | €162,955 | +€69,798 | +74.9% |
| Profit (loss) for the period to be appropriated | 9905 | €93,157 | €162,955 | +€69,798 | +74.9% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 28 October 2026 via checked.be.